GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PuriBlood Medical Co Ltd (ROCO:6847) » Definitions » EBITDA Margin %

PuriBlood Medical Co (ROCO:6847) EBITDA Margin % : -22.73% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is PuriBlood Medical Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. PuriBlood Medical Co's EBITDA for the six months ended in Jun. 2024 was NT$-7.6 Mil. PuriBlood Medical Co's Revenue for the six months ended in Jun. 2024 was NT$33.6 Mil. Therefore, PuriBlood Medical Co's EBITDA margin for the quarter that ended in Jun. 2024 was -22.73%.


PuriBlood Medical Co EBITDA Margin % Historical Data

The historical data trend for PuriBlood Medical Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PuriBlood Medical Co EBITDA Margin % Chart

PuriBlood Medical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial -509.15 8.95 -56.55 18.93 -35.90

PuriBlood Medical Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 9.07 47.13 -47.90 -31.74 -22.73

Competitive Comparison of PuriBlood Medical Co's EBITDA Margin %

For the Diagnostics & Research subindustry, PuriBlood Medical Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PuriBlood Medical Co's EBITDA Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PuriBlood Medical Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where PuriBlood Medical Co's EBITDA Margin % falls into.


;
;

PuriBlood Medical Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

PuriBlood Medical Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-44.977/125.268
=-35.90 %

PuriBlood Medical Co's EBITDA Margin % for the quarter that ended in Jun. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-7.631/33.576
=-22.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PuriBlood Medical Co  (ROCO:6847) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


PuriBlood Medical Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of PuriBlood Medical Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


PuriBlood Medical Co Business Description

Traded in Other Exchanges
N/A
Address
Gongye E. 9th Road, Baoshan Township, 2nd Floor, No.11, Hsinchu County, Baoshan, TWN
PuriBlood Medical Co Ltd is engaged in developing solutions for leukoreduction, cell separation, and anti-fouling materials. Its technology protects to supports living beings from medical devices to daily protection. The products of the company include Leukoreduction, Cell Separation, and P-tex.

PuriBlood Medical Co Headlines

No Headlines